Active Substance & Generic Molecule Directory
Orthosiphon Aristatus in Malaysia: Registered Brands, Dosages & Price Comparison
Directory of all approved pharmaceutical brands containing Orthosiphon Aristatus registered with the National Pharmaceutical Regulatory Agency (NPRA) / Ministry of Health Malaysia (KKM).
10
Registered Brands
Availability in Malaysia:10 Traditional (MAL-T)
Showing 10 of 10 registered brands
| MAL Reg No | Brand Formulation Name | Strength / Dosage | Classification | Registration Holder | Action |
|---|---|---|---|---|---|
| MAL24096200TC | 9 Misai Kucing 2gm Tea | 2 gm 2 gm | Traditional Herbal (MAL-T) | MILLION MEDICAL (PERAK) SDN.BERHAD | Compare → |
| MAL25086195TC | 9 Misai Kucing Plus Tea | 1600 mg 2 gm | Traditional Herbal (MAL-T) | MILLION MEDICAL (PERAK) SDN.BERHAD | Compare → |
| MAL25116114TC | Formula Herbs Misai Kucing 250mg Capsule | 250 mg 250 mg | Traditional Herbal (MAL-T) | SEANG WAN TRADING CO SDN BHD | Compare → |
| MAL12035034TC | KB Misai Kucing Tea | 2gm 2gm | Traditional Herbal (MAL-T) | KIN BIO GLOBAL SDN BHD | Compare → |
| MAL21046097TC | NewCo YANG SHEN CHA 2GM | 1.52gm 2 gm | Traditional Herbal (MAL-T) | TST HEALTH CARE SDN BHD | Compare → |
| MAL05061623TC | RAINFOREST HERBS MISAI KUCING PLUS CAPSULE | 100 mg 380 mg | Traditional Herbal (MAL-T) | ASIA BOTANICALS SDN. BHD. | Compare → |
| MAL05072142TC | RAINFOREST HERBS PEGAGA PLUS CAPSULE | 40 mg 350 mg | Traditional Herbal (MAL-T) | ASIA BOTANICALS SDN. BHD. | Compare → |
| MAL20033713T | SAW PALMETTO PLUS (CONTRINOL) | 200MG | Traditional Herbal (MAL-T) | HERBAL SCIENCE SDN. BHD. | Compare → |
| MAL25046100T | Wan Yeen Misai Kucing 2gm Tea | 2 gm 2 gm | Traditional Herbal (MAL-T) | WAN YEEN TRADING SDN. BHD. | Compare → |
| MAL25076151T | Wan Yeen Misai Kucing Plus Tea | 840 mg 2 gm | Traditional Herbal (MAL-T) | WAN YEEN TRADING SDN. BHD. | Compare → |
Generic Bioequivalence & Drug Substitution in Malaysia
Generic medications registered under NPRA contain the identical active pharmaceutical ingredient (API) in identical dosage strength and route of administration as the originator brand. NPRA requires rigorous bioequivalence (BE) studies demonstrating that generic drugs deliver the exact therapeutic effect. Always confirm with your doctor or community pharmacist before switching between prescription brands.